Cartalax 20MG
$65.00
Cartalax 20MG is a 20-milligram format of Cartalax, a short peptide fragment developed in Russian peptide bioregulator research. Researchers study Cartalax in preclinical and exploratory settings related to cartilage biology, extracellular matrix signaling, and connective tissue models. Interest often focuses on how small regulatory peptides may influence gene expression patterns in cell and tissue systems.
In Stock
Cartalax 20MG is a 20-milligram format of Cartalax, a peptide fragment described in peptide bioregulator literature and explored in experimental research involving cartilage and connective tissue biology. Studies have examined Cartalax 20MG in model systems used to investigate chondrocyte activity, extracellular matrix regulation, and tissue signaling pathways, with findings generally interpreted as preliminary and context dependent.
Because Cartalax is discussed as a low molecular weight regulatory peptide, it is often used in laboratory work where researchers compare peptide fragments for their potential to modulate transcriptional responses and cell behavior in culture or ex vivo preparations. Analytical characterization commonly focuses on identity confirmation and composition rather than therapeutic intent.
- Specification: 20MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Ripex-225 225mg/ml, 10 ml is a research compound supplied in a defined concentration and volume format. Researchers may reference Ripex-225 in analytical, stability, or method development work where consistent concentration labeling is required. This product is intended for laboratory workflows that document concentration and total volume as primary identifiers.
In Stock
Glutathione 1500MG is a 1500-milligram format of glutathione, a naturally occurring tripeptide made of glutamate, cysteine, and glycine. Researchers study glutathione in the context of cellular redox balance and antioxidant systems. It is also investigated in models involving detoxification pathways and oxidative stress biology.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
Metribolone 5mg/ml 10ml is a concentration and volume format of metribolone, a synthetic anabolic androgenic steroid also known as R1881. Researchers use metribolone as a high affinity androgen receptor agonist reference compound in receptor binding and transcriptional activity studies. It is commonly handled as a laboratory standard in endocrine and molecular pharmacology research.
In Stock
MT-2 Melanotan II Acetate 10MG is a 10-milligram format of melanotan II, a synthetic melanocortin peptide analogue related to alpha MSH. Researchers study it for its potential interaction with melanocortin receptors and downstream signaling in pigmentation and appetite models. Studies have also examined MT-2 Melanotan II Acetate 10MG in broader neuroendocrine research contexts.
In Stock
SNAP-8 – 10MG is a 10-milligram format of SNAP-8, a synthetic octapeptide commonly referred to as acetyl octapeptide 3. It is studied in cosmetic science as a topical model peptide related to SNAP-25 SNARE pathway research. Researchers have examined SNAP-8 in the context of peptide signalling and skin surface appearance studies.
In Stock
Glutathione – 600MG is a 600-milligram format of glutathione, a naturally occurring tripeptide made from glutamate, cysteine, and glycine. Researchers study glutathione in redox biology and oxidative stress models, including work focused on cellular antioxidant systems. It is also used in laboratory assays that examine thiol status and detoxification related pathways.
In Stock
MOTS-C 10MG is a 10-milligram format of MOTS-C, a 16 amino acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-C in relation to metabolic signaling, cellular stress responses, and mitochondrial nuclear communication in preclinical systems. Its small size and endogenous origin make it a common target in mechanistic peptide research.
In Stock
BPC-157 + TB-500 – 20MG combines two synthetic research peptides commonly discussed in preclinical recovery and tissue repair literature. BPC-157 is a 15 amino acid peptide originally derived from a gastric protective protein fragment, while TB-500 is a thymosin beta 4 related peptide fragment studied in models of cell migration and cytoskeletal dynamics. Researchers study this pairing in exploratory work involving connective tissue, angiogenesis signaling, and soft tissue research pathways.
In Stock
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
MOTS-C 40MG is a 40-milligram format of MOTS-c, a 16 amino acid mitochondrial derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-c for its potential role in cellular stress responses and metabolic signaling in preclinical models. Interest also includes how this peptide may interact with exercise related pathways and adaptive physiology.
In Stock
